We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current STTK market cap is 60.15M. The company's latest EPS is USD -1.8286 and P/E is -0.69.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 686k | 714k | 1.12M | 1.61M | 3M |
| Operating Income | -28.6M | -18.95M | -20.04M | -22.96M | -17.92M |
| Net Income | -27.54M | -17.69M | -18.5M | -21.55M | -16.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.89M | 9.93M | 30.02M | 652k | 1.66M |
| Operating Income | -25.07M | -36.93M | -45.27M | -103.33M | -91.96M |
| Net Income | -23.98M | -36.6M | -44.97M | -101.95M | -87.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 130.46M | 159.56M | 146.34M | 128.61M | 111.72M |
| Total Liabilities | 17.67M | 14.86M | 17.52M | 18M | 15.14M |
| Total Equity | 112.78M | 144.71M | 128.81M | 110.62M | 96.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.97M | 348.99M | 298.59M | 205.32M | 159.56M |
| Total Liabilities | 30.45M | 39.13M | 26.8M | 29.17M | 14.86M |
| Total Equity | -34.55M | 309.86M | 271.79M | 176.16M | 144.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -61.81M | -81.23M | -16.16M | -27.08M | -43.15M |
| Investing | 55.01M | 110.86M | -33.28M | -38.69M | -39.51M |
| Financing | 54k | 48.62M | -184k | 836k | 859k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.98M | -33.66M | -57.12M | -94.5M | -81.23M |
| Investing | -3.59M | -146.32M | -10.44M | 49.44M | 110.86M |
| Financing | -64k | 330.87M | 1.93M | 171k | 48.62M |
| Market Cap | 60.15M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 36.31 |
| Price to Cash Ratio | 0.48 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 47.74M |
| Average Volume (1 week) | 98.19k |
| Average Volume (1 Month) | 120.36k |
| 52 Week Change | -86.47% |
| 52 Week High | 11.76 |
| 52 Week Low | 0.94 |
| Spread (Intraday) | 0.06 (4.58%) |
| Company Name | Shattuck Labs Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://www.shattucklabs.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
